Puetzler Jan, Schulze Martin, Gosheger Georg, Schwarze Jan, Moellenbeck Burkhard, Theil Christoph
Department of Orthopaedics and Tumor Orthopaedics, University Hospital Muenster, Muenster, Germany.
Front Surg. 2023 Feb 17;10:1113006. doi: 10.3389/fsurg.2023.1113006. eCollection 2023.
The two-stage revision arthroplasty is a common treatment option for chronic periprosthetic infection (PJI). The time to reimplantation (TTR) reported in the literature varies substantially from a few days to several hundred days. It is hypothesized that longer TTR could be associated with worse infection control after second stage. A systematic literature search was performed according to Preferred Reporting items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, in Pubmed, Cochrane Library and Web of Science Core Collection in clinical studies published until January 2023. Eleven studies investigating TTR as a potential risk factor for reinfection met the inclusion criteria (ten retrospective and one prospective study, published 2012-2022). Study design and outcome measures differed notably. The cutoff points above which TTR was regarded as "long" ranged from 4 to 18 weeks. No study observed a benefit for long TTR. In all studies, similar or even better infection control was observed for short TTR. The optimal TTR, however, is not yet defined. Larger clinical studies with homogeneous patient populations and adjustment for confounding factors are needed.
两阶段翻修关节成形术是慢性假体周围感染(PJI)的常见治疗选择。文献报道的再植入时间(TTR)差异很大,从几天到几百天不等。据推测,较长的TTR可能与二期术后较差的感染控制相关。根据系统评价和Meta分析的首选报告项目(PRISMA)指南,在Pubmed、Cochrane图书馆和科学网核心合集中对截至2023年1月发表的临床研究进行了系统的文献检索。11项将TTR作为再感染潜在危险因素的研究符合纳入标准(10项回顾性研究和1项前瞻性研究,发表于2012 - 2022年)。研究设计和结局指标差异显著。TTR被视为“长”的截断点范围为4至18周。没有研究观察到长TTR有任何益处。在所有研究中,短TTR的感染控制情况相似甚至更好。然而,最佳TTR尚未确定。需要开展更大规模的临床研究,纳入同质化的患者群体并对混杂因素进行校正。